Mayne Pharma | MYX - UTANG

Keuangan

AUD

AUD 1.14B

AUD 110.07M

Biaya Penjualan

AUD 43.74M

AUD 460.59M

Kewajiban Lancar

AUD 313.94M

AUD 38.82M

AUD -16.2M

AUD 20.9M

450

Eps Laba Per Saham

AUD -0.15

Modal Dan Cadangan

AUD 454.19M

Laba Kotor Pada Penjualan

AUD 86.13M

Beban Bunga Utang

AUD 1.2M

AUD 2.66M

Kapitalisasi Pasar

AUD 232.25M

Batas Pemasukan

AUD -103.68M

Biaya Operasional

AUD 103.54M

Laba Operasional

AUD -3.3M

Modal Saham Biasa

AUD 81.25M

Laba Sebelum Pajak

AUD -14.7M

Pendapatan Penjualan

AUD 212.07M

Beban Penjualan Dan Administrasi

AUD 54.8M

AUD 74.63M

Kreditur Perdagangan

AUD 30.25M

Debitur Perdagangan

AUD 193.22M

	UTANG	Perubahan		Tanggal
Ansell	USD 805.6M		51.6M	2025-06
Avita Medical	AUD 46.05M		1.46M	2025-12
Cochlear	AUD 235.7M		10.9M	2025-06
CSL	USD 11.96B		219M	2024-12
Healius	AUD 1.4B		199.1M	2024-12
Integral Diagnostics	AUD 357.8M		3.7M	2024-06
Medical Developments International	AUD 1.99M		152K	2025-06
Nanosonics	AUD 7.69M		1.49M	2025-06
Polynovo	AUD 15.38M		49K	2024-06
Ramsay Health Care	AUD 12.12B		864.4M	2025-06
ResMed	USD 843.17M		3.18M	2026-03
Sigma Healthcare	AUD 137.64M		1.01M	2024-07
Sonic Healthcare	AUD 4.8B		282.9M	2024-12
Telix Pharmaceuticals	AUD 418.25M		163.2M	2025-06